SCHEMBL19346129

SCHEMBL19346129

C=C/C(=C\C=N/C)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21079026 0.82
SCHEMBL19217259 0.79
SCHEMBL27114647 0.79 TSHR (0.32)
SCHEMBL19400791 0.76
SCHEMBL26351518 0.76
SCHEMBL24199429 0.74
SCHEMBL18627202 0.74
SCHEMBL24106019 0.70 CA2 (0.33)
SCHEMBL14571153 0.70
SCHEMBL12447511 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230055250-A1 MAP4K4 INHIBITORS IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2023-02-23 US disclosed
US-11247973-B2 Antiviral benzodiazepine compounds THE UNIVERSITY OF DURHAM (GB) 2022-02-15 US disclosed
US-9951053-B2 γ-diketones as Wnt/β-catenin signaling pathway activators SAMUMED, LLC (US) 2018-04-24 US disclosed
US-20170260176-A1 GAMMA-DIKETONES AS WNT/BETA -CATENIN SIGNALING PATHWAY ACTIVATORS MED-PATHWAYS II LIMITED (VG) 2017-09-14 US disclosed